Adial Pharmaceuticals, Inc.
ADIL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001513525
In the last 90 days, Adial Pharmaceuticals, Inc. insiders filed 3 open-market purchases and 0 sales; 17 institutions reported holding it in 13F filings for Q2 2026, worth $334.6K in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Adial Pharmaceuticals, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- +3 vs. Q3 2021
- Shares held
- 1.34M
- +52.4K (+4.1%) vs. Q3 2021
- Total value
- $3.61M
- −$1.90M (−34.5%) vs. Q3 2021
- New holders
- 5
- 3 more added
- Sold out
- 2
- 4 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADIL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $334.6K |
| Q1 2026 | 15 | $63.8K |
| Q4 2025 | 24 | $778.4K |
| Q3 2025 | 17 | $214.8K |
| Q2 2025 | 17 | $70.8K |
| Q1 2025 | 14 | $152.7K |
| Q4 2024 | 15 | $298.1K |
| Q3 2024 | 12 | $195.9K |
| Q2 2024 | 16 | $328.0K |
| Q1 2024 | 16 | $236.2K |
| Q4 2023 | 17 | $495.3K |
| Q3 2023 | 11 | $164.2K |
| Q2 2023 | 21 | $488.2K |
| Q1 2023 | 23 | $876.9K |
| Q4 2022 | 23 | $359.2K |
| Q3 2022 | 28 | $692.1K |
| Q2 2022 | 26 | $2.27M |
| Q1 2022 | 23 | $6.38M |
| Q4 2021 | 24 | $3.61M |
| Q3 2021 | 21 | $5.50M |
| Q2 2021 | 19 | $3.15M |
| Q1 2021 | 20 | $1.95M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Adial Pharmaceuticals, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 590,852 | $1.59M | 0.00% | −3,591−0.6% | Reduced |
| BlackRock Inc. | 227,178 | $613.0K | 0.00% | +31,923+16.3% | Added |
| Geode Capital Management, LLC | 129,327 | $349.0K | 0.00% | +33,250+34.6% | Added |
| State Street Corp | 50,154 | $135.0K | 0.00% | 00.0% | Unchanged |
| Raffa Wealth Management, LLC | 41,845 | $113.0K | 0.04% | 00.0% | Unchanged |
| Oppenheimer & Co Inc | 38,500 | $104.0K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 36,461 | $98.0K | 0.00% | 00.0% | Unchanged |
| Private Advisor Group, LLC | 34,150 | $92.0K | 0.00% | −1,250−3.5% | Reduced |
| Dimensional Fund Advisors LP | 31,410 | $85.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 29,299 | $79.0K | 0.00% | 00.0% | Unchanged |
| Brown Advisory Inc | 26,040 | $70.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 20,746 | $56.0K | 0.00% | +3,697+21.7% | Added |
| Goldman Sachs Group Inc | 19,526 | $53.0K | 0.00% | +19,526 | New |
| Rede Wealth, LLC | 15,200 | $41.0K | 0.02% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 12,192 | $33.0K | 0.00% | +12,192 | New |
| Charles Schwab Investment Management Inc | 11,609 | $32.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 8,321 | $22.0K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 6,200 | $17.0K | 0.00% | +6,200 | New |
| UBS Group AG | 3,624 | $10.0K | 0.00% | −766−17.4% | Reduced |
| Benjamin F. Edwards & Company, Inc. | 1,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| High Net Worth Advisory Group LLC | 1,000 | $3.00K | 0.00% | +1,000 | New |
| Wells Fargo & Company | 865 | $2.00K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 538 | $1.00K | 0.00% | −39,690−98.7% | Reduced |
| Cornerstone Advisory, LLC | 25 | $0 | 0.00% | +25 | New |
| NorthRock Partners, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −95−100.0% | Sold out |